LakeShore Biopharma Co., Ltd (LSB NASDAQ) stock market data APIs
$0.838
0(0%)
as of September 12, 2025
Try our APIs with
free plan!
LakeShore Biopharma Co., Ltd Financial Data Overview
Price chart is built with
Anychart
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
Prev. Close
0.838
Open
0.8425
High
0.8732
Low
0.8091
52 wk Range
0.59-8.6
Market Cap
34 227 K
Shares Outstanding
41 213 K
Revenue
615 M
Beta
0.57
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LakeShore Biopharma Co., Ltd data using free add-ons & libraries
Get LakeShore Biopharma Co., Ltd Fundamental Data
LakeShore Biopharma Co., Ltd Fundamental data includes:
- Net Revenue: 615 M
- EBITDA: -12 925 235
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-18
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LakeShore Biopharma Co., Ltd News
New
LakeShore Biopharma receives $0.86/share buyout proposal from Oceanpine Capital
* Oceanpine Capital submitted a preliminary non-binding proposal to acquire all outstanding shares of LakeShore Biopharma (NASDAQ:LSB [https://seekingalpha.com/symbol/LSB]) not already owned. * Th...
LakeShore Biopharma secures $15 million in private placement
BEIJING - LakeShore Biopharma Co., Ltd (NASDAQ:LSB), a biopharmaceutical company focused on vaccines and therapeutic biologics with a current market capitalization of $18.71 million, announced Tuesday...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
